• COVID-safe measures such as telehealth consults for trials, and local deliveries of trial medicines are now serving to improve clinical trial processes beyond the pandemic
• Australia’s contribution to global clinical trials continues to grow, telehealth and other digital measures offer potential to increase access via ‘teletrials’
• In 2020 Novartis contributed to 141 Australian studies, with an investment of AUD20m1
With COVID-19 restrictions significantly impacting on traditional ways of working, Novartis Australia is offering associates the choice to decide how, where and when they work.
Novartis’ new flexible working model forms the basis of the organisation’s long-term vision for redefining how associates create the greatest impact in their role.
The “unbossed” future working model empowers associates to take personal responsibility to inform managers about their working schedule and align with teammates for effective collaboration.
COVID-19 is significantly impacting patient organisations’ ability to undertake their critical work as funds and resources are diverted to COVID-19 initiatives
As these patient organisations are altering their essential services to provide greater proactive outreach to patients, revenues from donations and community initiatives have slowed, or even stopped
Novartis Australia has rolled out funding for COVID-19 related programs, support for mental health and stepped up its promotion of partner patient organisation campaigns
Novartis Australia, and its generics and biosimilars division Sandoz, has confirmed that it will be working with the Australian government to provide an initial supply of generic hydroxychloroquine to support the COVID-19 pandemic response.
Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.
Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.
Up to 8,800 hospital admissions and hundreds of deaths could be prevented, according to first Seasonal Vulnerability Report1
Thousands of older Australians are being hospitalised as temperatures plummet across Australia, with a new report revealing a 32 per cent spike in admissions during winter compared to summer for deadly and common heart conditions.1
